Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-04

Clinical Trial Update: A Study to Assess the Relative Bioavailability Three New Formulations of Telaprevir in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial in healthy subjects comparing the relative bioavailability of three new telaprevir formulations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telaprevir (telaprevir)

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Chronic Hepatitis C | Phase 1 | Status: COMPLETED